BioNTech terminates Phase 2 trial of autogene cevumeran in colorectal cancer
DSMB recommended discontinuing treatment of patients in the Phase 2 trial and terminating the clinical trial.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.